National Lung Cancer Registry in Men and Women based on Diagnosis in Algeria

Trial Identifier: D133FR00108
Sponsor: AstraZeneca
NCTID:: NCT02725892
Start Date: July 2016
Primary Completion Date: February 2021
Study Completion Date: February 2021
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations